{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T07:55:12Z","timestamp":1790150112637,"version":"4.0.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,1,31]],"date-time":"2013-01-31T00:00:00Z","timestamp":1359590400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s00401-013-1086-9","type":"journal-article","created":{"date-parts":[[2013,1,30]],"date-time":"2013-01-30T12:51:33Z","timestamp":1359550293000},"page":"535-547","source":"Crossref","is-referenced-by-count":55,"title":["Brain regional correlation of amyloid-\u03b2 with synapses and apolipoprotein E in non-demented individuals: potential mechanisms underlying regional vulnerability to amyloid-\u03b2 accumulation"],"prefix":"10.1007","volume":"125","author":[{"given":"Mitsuru","family":"Shinohara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis W.","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojun","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,31]]},"reference":[{"key":"1086_CR1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0006-8993(01)02390-3","volume":"902","author":"H Akiyama","year":"2001","unstructured":"Akiyama H, Kondo H, Ikeda K, Kato M, McGeer PL (2001) Immunohistochemical localization of neprilysin in the human cerebral cortex: inverse association with vulnerability to amyloid beta-protein (Abeta) deposition. Brain Res 902:277\u2013281","journal-title":"Brain Res"},{"key":"1086_CR2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00401-011-0892-1","volume":"123","author":"S Arold","year":"2012","unstructured":"Arold S, Sullivan P, Bilousova T et al (2012) Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer\u2019s disease and apoE TR mouse cortex. Acta Neuropathol 123:39\u201352","journal-title":"Acta Neuropathol"},{"key":"1086_CR3","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1523\/JNEUROSCI.0887-09.2009","volume":"29","author":"KR Bales","year":"2009","unstructured":"Bales KR, Liu F, Wu S et al (2009) Human APOE isoform-dependent effects on brain beta-amyloid levels in PDAPP transgenic mice. J Neurosci 29:6771\u20136779. doi: 10.1523\/jneurosci.0887-09.2009","journal-title":"J Neurosci"},{"key":"1086_CR4","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0140-6736(10)61349-9","volume":"377","author":"C Ballard","year":"2011","unstructured":"Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E (2011) Alzheimer\u2019s disease. Lancet 377:1019\u20131031. doi: 10.1016\/s0140-6736(10)61349-9","journal-title":"Lancet"},{"key":"1086_CR5","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1006\/exnr.1997.6487","volume":"145","author":"SA Benkovic","year":"1997","unstructured":"Benkovic SA, McGowan EM, Rothwell NJ, Hutton M, Morgan DG, Gordon MN (1997) Regional and cellular localization of presenilin-2 RNA in rat and human brain. Exp Neurol 145:555\u2013564. doi: 10.1006\/exnr.1997.6487","journal-title":"Exp Neurol"},{"key":"1086_CR6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0304-3940(99)00135-4","volume":"263","author":"HG Bernstein","year":"1999","unstructured":"Bernstein HG, Ansorge S, Riederer P, Reiser M, Frolich L, Bogerts B (1999) Insulin-degrading enzyme in the Alzheimer\u2019s disease brain: prominent localization in neurons and senile plaques. Neurosci Lett 263:161\u2013164","journal-title":"Neurosci Lett"},{"key":"1086_CR7","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nn.2801","volume":"14","author":"AW Bero","year":"2011","unstructured":"Bero AW, Yan P, Roh JH et al (2011) Neuronal activity regulates the regional vulnerability to amyloid-beta deposition. Nat Neurosci 14:750\u2013756. doi: 10.1038\/nn.2801","journal-title":"Nat Neurosci"},{"key":"1086_CR8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 82:239\u2013259","journal-title":"Acta Neuropathol"},{"key":"1086_CR9","doi-asserted-by":"crossref","first-page":"558","DOI":"10.2741\/s85","volume":"2","author":"V Bramanti","year":"2010","unstructured":"Bramanti V, Tomassoni D, Avitabile M, Amenta F, Avola R (2010) Biomarkers of glial cell proliferation and differentiation in culture. Front Biosci 2:558\u2013570","journal-title":"Front Biosci"},{"key":"1086_CR10","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nrn2620","volume":"10","author":"G Bu","year":"2009","unstructured":"Bu G (2009) Apolipoprotein E and its receptors in Alzheimer\u2019s disease: pathways, pathogenesis and therapy. Nat Rev Neurosci 10:333\u2013344. doi: 10.1038\/nrn2620","journal-title":"Nat Rev Neurosci"},{"key":"1086_CR11","doi-asserted-by":"crossref","first-page":"7709","DOI":"10.1523\/JNEUROSCI.2177-05.2005","volume":"25","author":"RL Buckner","year":"2005","unstructured":"Buckner RL, Snyder AZ, Shannon BJ et al (2005) Molecular, structural, and functional characterization of Alzheimer\u2019s disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci 25:7709\u20137717. doi: 10.1523\/jneurosci.2177-05.2005","journal-title":"J Neurosci"},{"key":"1086_CR12","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/S0022-2275(20)37904-9","volume":"24","author":"MC Camus","year":"1983","unstructured":"Camus MC, Chapman MJ, Forgez P, Laplaud PM (1983) Distribution and characterization of the serum lipoproteins and apoproteins in the mouse, Mus musculus. J Lipid Res 24:1210\u20131228","journal-title":"J Lipid Res"},{"key":"1086_CR13","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1096\/fj.09-141754","volume":"24","author":"P Chakrabarty","year":"2010","unstructured":"Chakrabarty P, Jansen-West K, Beccard A et al (2010) Massive gliosis induced by interleukin-6 suppresses Abeta deposition in vivo: evidence against inflammation as a driving force for amyloid deposition. FASEB J 24:548\u2013559. doi: 10.1096\/fj.09-141754","journal-title":"FASEB J"},{"key":"1086_CR14","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.neuron.2005.10.028","volume":"48","author":"JR Cirrito","year":"2005","unstructured":"Cirrito JR, Yamada KA, Finn MB et al (2005) Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron 48:913\u2013922. doi: 10.1016\/j.neuron.2005.10.028","journal-title":"Neuron"},{"key":"1086_CR15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrneurol.2009.218","volume":"6","author":"B Strooper De","year":"2010","unstructured":"De Strooper B, Vassar R, Golde T (2010) The secretases: enzymes with therapeutic potential in Alzheimer disease. Nat Rev Neurol 6:99\u2013107","journal-title":"Nat Rev Neurol"},{"key":"1086_CR16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1750-1326-4-39","volume":"4","author":"A Delledonne","year":"2009","unstructured":"Delledonne A, Kouri N, Reinstatler L et al (2009) Development of monoclonal antibodies and quantitative ELISAs targeting insulin-degrading enzyme. Mol Neurodegener 4:39. doi: 10.1186\/1750-1326-4-39","journal-title":"Mol Neurodegener"},{"key":"1086_CR17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0197-4580(92)90027-U","volume":"13","author":"DW Dickson","year":"1992","unstructured":"Dickson DW, Crystal HA, Mattiace LA et al (1992) Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging 13:179\u2013189","journal-title":"Neurobiol Aging"},{"key":"1086_CR18","doi-asserted-by":"crossref","first-page":"30471","DOI":"10.1074\/jbc.M605827200","volume":"281","author":"EA Eckman","year":"2006","unstructured":"Eckman EA, Adams SK, Troendle FJ et al (2006) Regulation of steady-state beta-amyloid levels in the brain by neprilysin and endothelin-converting enzyme but not angiotensin-converting enzyme. J Biol Chem 281:30471\u201330478. doi: 10.1074\/jbc.M605827200","journal-title":"J Biol Chem"},{"key":"1086_CR19","doi-asserted-by":"crossref","first-page":"e11884","DOI":"10.1371\/journal.pone.0011884","volume":"5","author":"RA Fuentealba","year":"2010","unstructured":"Fuentealba RA, Liu Q, Zhang J et al (2010) Low-density lipoprotein receptor-related protein 1 (LRP1) mediates neuronal Abeta42 uptake and lysosomal trafficking. PLoS One 5:e11884. doi: 10.1371\/journal.pone.0011884","journal-title":"PLoS One"},{"key":"1086_CR20","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1002\/j.1460-2075.1987.tb02694.x","volume":"6","author":"M Goedert","year":"1987","unstructured":"Goedert M (1987) Neuronal localization of amyloid beta protein precursor mRNA in normal human brain and in Alzheimer\u2019s disease. EMBO J 6:3627\u20133632","journal-title":"EMBO J"},{"key":"1086_CR21","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0022-2275(20)39681-4","volume":"34","author":"S Goulinet","year":"1993","unstructured":"Goulinet S, Chapman MJ (1993) Plasma lipoproteins in the golden Syrian hamster (Mesocricetus auratus): heterogeneity of apoB- and apoA-I-containing particles. J Lipid Res 34:943\u2013959","journal-title":"J Lipid Res"},{"key":"1086_CR22","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1212\/WNL.0b013e318211c352","volume":"76","author":"VB Gupta","year":"2011","unstructured":"Gupta VB, Laws SM, Villemagne VL et al (2011) Plasma apolipoprotein E and Alzheimer disease risk: the AIBL study of aging. Neurology 76:1091\u20131098","journal-title":"Neurology"},{"key":"1086_CR23","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/sj.ejhg.5200864","volume":"10","author":"N Haddy","year":"2002","unstructured":"Haddy N, De Bacquer D, Chemaly MM et al (2002) The importance of plasma apolipoprotein E concentration in addition to its common polymorphism on inter-individual variation in lipid levels: results from Apo Europe. Eur J Hum Genet 10:841\u2013850","journal-title":"Eur J Hum Genet"},{"key":"1086_CR24","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/1531-8249(200006)47:6<739::AID-ANA6>3.0.CO;2-8","volume":"47","author":"DM Holtzman","year":"2000","unstructured":"Holtzman DM, Fagan AM, Mackey B et al (2000) Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer\u2019s disease model. Ann Neurol 47:739\u2013747","journal-title":"Ann Neurol"},{"key":"1086_CR25","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1126\/science.1059946","volume":"292","author":"N Iwata","year":"2001","unstructured":"Iwata N, Tsubuki S, Takaki Y et al (2001) Metabolic regulation of brain Abeta by neprilysin. Science 292:1550\u20131552. doi: 10.1126\/science.1059946","journal-title":"Science"},{"key":"1086_CR26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","volume":"9","author":"CR Jack Jr","year":"2010","unstructured":"Jack CR Jr, Knopman DS, Jagust WJ et al (2010) Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade. Lancet Neurol 9:119\u2013128. doi: 10.1016\/s1474-4422(09)70299-6","journal-title":"Lancet Neurol"},{"key":"1086_CR27","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/brain\/awp062","volume":"132","author":"CR Jack Jr","year":"2009","unstructured":"Jack CR Jr, Lowe VJ, Weigand SD et al (2009) Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer\u2019s disease: implications for sequence of pathological events in Alzheimer\u2019s disease. Brain 132:1355\u20131365. doi: 10.1093\/brain\/awp062","journal-title":"Brain"},{"key":"1086_CR28","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1093\/brain\/awq277","volume":"133","author":"CR Jack Jr","year":"2010","unstructured":"Jack CR Jr, Wiste HJ, Vemuri P et al (2010) Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer\u2019s disease. Brain 133:3336\u20133348","journal-title":"Brain"},{"key":"1086_CR29","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.neuron.2008.04.010","volume":"58","author":"Q Jiang","year":"2008","unstructured":"Jiang Q, Lee CY, Mandrekar S et al (2008) ApoE promotes the proteolytic degradation of Abeta. Neuron 58:681\u2013693. doi: 10.1016\/j.neuron.2008.04.010","journal-title":"Neuron"},{"key":"1086_CR30","doi-asserted-by":"crossref","first-page":"16458","DOI":"10.1523\/JNEUROSCI.3987-12.2012","volume":"32","author":"T Kanekiyo","year":"2012","unstructured":"Kanekiyo T, Liu CC, Shinohara M, Li J, Bu G (2012) LRP1 in brain vascular smooth muscle cells mediates local clearance of Alzheimer\u2019s amyloid-beta. J Neurosci 32:16458\u201316465. doi: 10.1523\/jneurosci.3987-12.2012","journal-title":"J Neurosci"},{"key":"1086_CR31","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1523\/JNEUROSCI.5491-10.2011","volume":"31","author":"T Kanekiyo","year":"2011","unstructured":"Kanekiyo T, Zhang J, Liu Q, Liu CC, Zhang L, Bu G (2011) Heparan sulphate proteoglycan and the low-density lipoprotein receptor-related protein 1 constitute major pathways for neuronal amyloid-beta uptake. J Neurosci 31:1644\u20131651. doi: 10.1523\/jneurosci.5491-10.2011","journal-title":"J Neurosci"},{"key":"1086_CR32","doi-asserted-by":"crossref","first-page":"18007","DOI":"10.1523\/JNEUROSCI.3773-11.2011","volume":"31","author":"J Kim","year":"2011","unstructured":"Kim J, Jiang H, Park S et al (2011) Haploinsufficiency of human APOE reduces amyloid deposition in a mouse model of amyloid-beta amyloidosis. J Neurosci 31:18007\u201318012. doi: 10.1523\/jneurosci.3773-11.2011","journal-title":"J Neurosci"},{"key":"1086_CR33","doi-asserted-by":"crossref","first-page":"6174","DOI":"10.1523\/JNEUROSCI.0730-07.2007","volume":"27","author":"WE Klunk","year":"2007","unstructured":"Klunk WE, Price JC, Mathis CA et al (2007) Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. J Neurosci 27:6174\u20136184. doi: 10.1523\/jneurosci.0730-07.2007","journal-title":"J Neurosci"},{"key":"1086_CR34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1750-1326-6-63","volume":"6","author":"R Koffie","year":"2011","unstructured":"Koffie R, Hyman B, Spires-Jones T (2011) Alzheimer\u2019s disease: synapses gone cold. Molecular Neurodegeneration 6:63","journal-title":"Molecular Neurodegeneration"},{"key":"1086_CR35","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1093\/brain\/aws127","volume":"135","author":"RM Koffie","year":"2012","unstructured":"Koffie RM, Hashimoto T, Tai HC et al (2012) Apolipoprotein E4 effects in Alzheimer\u2019s disease are mediated by synaptotoxic oligomeric amyloid-beta. Brain 135:2155\u20132168","journal-title":"Brain"},{"key":"1086_CR36","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1073\/pnas.0811698106","volume":"106","author":"RM Koffie","year":"2009","unstructured":"Koffie RM, Meyer-Luehmann M, Hashimoto T et al (2009) Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques. Proc Natl Acad Sci USA 106:4012\u20134017. doi: 10.1073\/pnas.0811698106","journal-title":"Proc Natl Acad Sci USA"},{"key":"1086_CR37","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nm1058","volume":"10","author":"M Koistinaho","year":"2004","unstructured":"Koistinaho M, Lin S, Wu X et al (2004) Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides. Nat Med 10:719\u2013726. doi: 10.1038\/nm1058","journal-title":"Nat Med"},{"key":"1086_CR38","doi-asserted-by":"crossref","first-page":"9785","DOI":"10.1523\/JNEUROSCI.22-22-09785.2002","volume":"22","author":"O Lazarov","year":"2002","unstructured":"Lazarov O, Lee M, Peterson DA, Sisodia SS (2002) Evidence that synaptically released beta-amyloid accumulates as extracellular deposits in the hippocampus of transgenic mice. J Neurosci 22:9785\u20139793","journal-title":"J Neurosci"},{"key":"1086_CR39","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0896-6273(03)00787-6","volume":"40","author":"MA Leissring","year":"2003","unstructured":"Leissring MA, Farris W, Chang AY et al (2003) Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron 40:1087\u20131093","journal-title":"Neuron"},{"key":"1086_CR40","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1523\/JNEUROSCI.17-01-00140.1997","volume":"17","author":"NR Marquez-Sterling","year":"1997","unstructured":"Marquez-Sterling NR, Lo AC, Sisodia SS, Koo EH (1997) Trafficking of cell-surface beta-amyloid precursor protein: evidence that a sorting intermediate participates in synaptic vesicle recycling. J Neurosci 17:140\u2013151","journal-title":"J Neurosci"},{"key":"1086_CR41","doi-asserted-by":"crossref","first-page":"8872","DOI":"10.1128\/MCB.24.20.8872-8883.2004","volume":"24","author":"P May","year":"2004","unstructured":"May P, Rohlmann A, Bock HH et al (2004) Neuronal LRP1 functionally associates with postsynaptic proteins and is required for normal motor function in mice. Mol Cell Biol 24:8872\u20138883. doi: 10.1128\/mcb.24.20.8872-8883.2004","journal-title":"Mol Cell Biol"},{"key":"1086_CR42","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1523\/JNEUROSCI.2984-08.2009","volume":"29","author":"WJ Meilandt","year":"2009","unstructured":"Meilandt WJ, Cisse M, Ho K et al (2009) Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic Abeta oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice. J Neurosci 29:1977\u20131986. doi: 10.1523\/jneurosci.2984-08.2009","journal-title":"J Neurosci"},{"key":"1086_CR43","doi-asserted-by":"crossref","first-page":"6221","DOI":"10.1073\/pnas.1031520100","volume":"100","author":"BC Miller","year":"2003","unstructured":"Miller BC, Eckman EA, Sambamurti K et al (2003) Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo. Proc Natl Acad Sci USA 100:6221\u20136226. doi: 10.1073\/pnas.1031520100","journal-title":"Proc Natl Acad Sci USA"},{"key":"1086_CR44","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1371\/journal.pmed.0030176","volume":"3","author":"SP Mooijaart","year":"2006","unstructured":"Mooijaart SP, Berbee JF, van Heemst D et al (2006) ApoE plasma levels and risk of cardiovascular mortality in old age. PLoS Med 3:9","journal-title":"PLoS Med"},{"key":"1086_CR45","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0169-409X(02)00162-X","volume":"54","author":"AH Moore","year":"2002","unstructured":"Moore AH, O\u2019Banion MK (2002) Neuroinflammation and anti-inflammatory therapy for Alzheimer\u2019s disease. Adv Drug Deliv Rev 54:1627\u20131656","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"1086_CR46","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/alzrt121","volume":"4","author":"BD Moore","year":"2012","unstructured":"Moore BD, Chakrabarty P, Levites Y et al (2012) Overlapping profiles of Abeta peptides in the Alzheimer\u2019s disease and pathological aging brains. Alzheimers Res Ther 4(3):18","journal-title":"Alzheimers Res Ther"},{"key":"1086_CR47","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.21843","volume":"67","author":"JC Morris","year":"2010","unstructured":"Morris JC, Roe CM, Xiong C et al (2010) APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging. Ann Neurol 67:122\u2013131. doi: 10.1002\/ana.21843","journal-title":"Ann Neurol"},{"key":"1086_CR48","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1471-4159.2011.07510.x","volume":"1","author":"NN Nalivaeva","year":"2012","unstructured":"Nalivaeva NN, Beckett C, Belyaev ND, Turner AJ (2012) Are amyloid-degrading enzymes viable therapeutic targets in Alzheimer\u2019s disease? J Neurochem 1:167\u2013185","journal-title":"J Neurochem"},{"key":"1086_CR49","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1212\/WNL.0b013e3181b23564","volume":"73","author":"A Okello","year":"2009","unstructured":"Okello A, Koivunen J, Edison P et al (2009) Conversion of amyloid positive and negative MCI to AD over 3\u00a0years: an 11C-PIB PET study. Neurology 73:754\u2013760","journal-title":"Neurology"},{"key":"1086_CR50","doi-asserted-by":"crossref","first-page":"14020","DOI":"10.1073\/pnas.93.24.14020","volume":"93","author":"K Page","year":"1996","unstructured":"Page K, Hollister R, Tanzi RE, Hyman BT (1996) In situ hybridization analysis of presenilin 1 mRNA in Alzheimer disease and in lesioned rat brain. Proc Natl Acad Sci USA 93:14020\u201314024","journal-title":"Proc Natl Acad Sci USA"},{"key":"1086_CR51","doi-asserted-by":"crossref","first-page":"10625","DOI":"10.1073\/pnas.91.22.10625","volume":"91","author":"L Pellerin","year":"1994","unstructured":"Pellerin L, Magistretti PJ (1994) Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci USA 91:10625\u201310629","journal-title":"Proc Natl Acad Sci USA"},{"key":"1086_CR52","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/glia.20772","volume":"57","author":"A Pocivavsek","year":"2009","unstructured":"Pocivavsek A, Burns MP, Rebeck GW (2009) Low-density lipoprotein receptors regulate microglial inflammation through c-Jun N-terminal kinase. Glia 57:444\u2013453. doi: 10.1002\/glia.20772","journal-title":"Glia"},{"key":"1086_CR53","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.1073\/pnas.0900345106","volume":"106","author":"EM Reiman","year":"2009","unstructured":"Reiman EM, Chen K, Liu X et al (2009) Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer\u2019s disease. Proc Natl Acad Sci USA 106:6820\u20136825. doi: 10.1073\/pnas.0900345106","journal-title":"Proc Natl Acad Sci USA"},{"key":"1086_CR54","doi-asserted-by":"crossref","first-page":"11445","DOI":"10.1523\/JNEUROSCI.1972-08.2008","volume":"28","author":"DR Riddell","year":"2008","unstructured":"Riddell DR, Zhou H, Atchison K et al (2008) Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels. J Neurosci 28:11445\u201311453","journal-title":"J Neurosci"},{"key":"1086_CR55","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm1782","volume":"14","author":"GM Shankar","year":"2008","unstructured":"Shankar GM, Li S, Mehta TH et al (2008) Amyloid-beta protein dimers isolated directly from Alzheimer\u2019s brains impair synaptic plasticity and memory. Nat Med 14:837\u2013842. doi: 10.1038\/nm1782","journal-title":"Nat Med"},{"key":"1086_CR56","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI10498","volume":"106","author":"M Shibata","year":"2000","unstructured":"Shibata M, Yamada S, Kumar SR et al (2000) Clearance of Alzheimer\u2019s amyloid-ss(1\u201340) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest 106:1489\u20131499. doi: 10.1172\/jci10498","journal-title":"J Clin Invest"},{"key":"1086_CR57","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0006-8993(92)91697-D","volume":"592","author":"K Shigematsu","year":"1992","unstructured":"Shigematsu K, McGeer PL, McGeer EG (1992) Localization of amyloid precursor protein in selective postsynaptic densities of rat cortical neurons. Brain Res 592:353\u2013357","journal-title":"Brain Res"},{"key":"1086_CR58","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.nbd.2011.08.027","volume":"45","author":"S Sokolow","year":"2012","unstructured":"Sokolow S, Luu SH, Nandy K et al (2012) Preferential accumulation of amyloid-beta in presynaptic glutamatergic terminals (VGluT1 and VGluT2) in Alzheimer\u2019s disease cortex. Neurobiol Dis 45:381\u2013387","journal-title":"Neurobiol Dis"},{"key":"1086_CR59","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1471-4159.2011.07419.x","volume":"119","author":"J Suh","year":"2011","unstructured":"Suh J, Lyckman A, Wang L, Eckman EA, Guenette SY (2011) FE65 proteins regulate NMDA receptor activation-induced amyloid precursor protein processing. J Neurochem 119:377\u2013388","journal-title":"J Neurochem"},{"key":"1086_CR60","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.neurobiolaging.2009.05.011","volume":"32","author":"PM Sullivan","year":"2011","unstructured":"Sullivan PM, Han B, Liu F et al (2011) Reduced levels of human apoE4 protein in an animal model of cognitive impairment. Neurobiol Aging 32:791\u2013801","journal-title":"Neurobiol Aging"},{"key":"1086_CR61","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/S0002-9440(10)64463-X","volume":"161","author":"RH Takahashi","year":"2002","unstructured":"Takahashi RH, Milner TA, Li F et al (2002) Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am J Pathol 161:1869\u20131879","journal-title":"Am J Pathol"},{"key":"1086_CR62","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0006-8993(96)01274-7","volume":"748","author":"K Takami","year":"1997","unstructured":"Takami K, Terai K, Matsuo A, Walker DG, McGeer PL (1997) Expression of presenilin-1 and -2 mRNAs in rat and Alzheimer\u2019s disease brains. Brain Res 748:122\u2013130","journal-title":"Brain Res"},{"key":"1086_CR63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2012.04.021","volume":"236","author":"DR Thal","year":"2012","unstructured":"Thal DR (2012) The role of astrocytes in amyloid beta-protein toxicity and clearance. Exp Neurol 236:1\u20135","journal-title":"Exp Neurol"},{"key":"1086_CR64","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal DR, Rub U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791\u20131800","journal-title":"Neurology"},{"key":"1086_CR65","doi-asserted-by":"crossref","first-page":"29615","DOI":"10.1074\/jbc.R800019200","volume":"283","author":"G Thinakaran","year":"2008","unstructured":"Thinakaran G, Koo EH (2008) Amyloid precursor protein trafficking, processing, and function. J Biol Chem 283:29615\u201329619. doi: 10.1074\/jbc.R800019200","journal-title":"J Biol Chem"},{"key":"1086_CR66","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.286.5440.735","volume":"286","author":"R Vassar","year":"1999","unstructured":"Vassar R, Bennett BD, Babu-Khan S et al (1999) Beta-secretase cleavage of Alzheimer\u2019s amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286:735\u2013741","journal-title":"Science"},{"key":"1086_CR67","doi-asserted-by":"crossref","first-page":"11328","DOI":"10.1523\/JNEUROSCI.0607-11.2011","volume":"31","author":"DK Verges","year":"2011","unstructured":"Verges DK, Restivo JL, Goebel WD, Holtzman DM, Cirrito JR (2011) Opposing synaptic regulation of amyloid-beta metabolism by NMDA receptors in vivo. J Neurosci 31:11328\u201311337","journal-title":"J Neurosci"},{"key":"1086_CR68","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1001\/archneurol.2009.285","volume":"66","author":"VL Villemagne","year":"2009","unstructured":"Villemagne VL, Ataka S, Mizuno T et al (2009) High striatal amyloid beta-peptide deposition across different autosomal Alzheimer disease mutation types. Arch Neurol 66:1537\u20131544. doi: 10.1001\/archneurol.2009.285","journal-title":"Arch Neurol"},{"key":"1086_CR69","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.22248","volume":"69","author":"VL Villemagne","year":"2011","unstructured":"Villemagne VL, Pike KE, Chetelat G et al (2011) Longitudinal assessment of Abeta and cognition in aging and Alzheimer disease. Ann Neurol 69:181\u2013192","journal-title":"Ann Neurol"},{"key":"1086_CR70","doi-asserted-by":"crossref","first-page":"17763","DOI":"10.1073\/pnas.1010461107","volume":"107","author":"AG Vlassenko","year":"2010","unstructured":"Vlassenko AG, Vaishnavi SN, Couture L et al (2010) Spatial correlation between brain aerobic glycolysis and amyloid-beta (Abeta) deposition. Proc Natl Acad Sci USA 107:17763\u201317767. doi: 10.1073\/pnas.1010461107","journal-title":"Proc Natl Acad Sci USA"},{"key":"1086_CR71","first-page":"7","volume":"9","author":"GL Wenk","year":"2003","unstructured":"Wenk GL (2003) Neuropathologic changes in Alzheimer\u2019s disease. J Clin Psychiatry 9:7\u201310","journal-title":"J Clin Psychiatry"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-013-1086-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-013-1086-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-013-1086-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T00:19:39Z","timestamp":1644193179000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-013-1086-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,31]]},"references-count":71,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["1086"],"URL":"https:\/\/doi.org\/10.1007\/s00401-013-1086-9","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,31]]}}}